96 related articles for article (PubMed ID: 2543223)
1. Serum lipoprotein effects of conjugated estrogen and a sequential conjugated estrogen-medrogestone regimen in hysterectomized postmenopausal women.
Sonnendecker EW; Polakow ES; Benadé AJ; Simchowitz E
Am J Obstet Gynecol; 1989 May; 160(5 Pt 1):1128-34. PubMed ID: 2543223
[TBL] [Abstract][Full Text] [Related]
2. The effect of medrogestone on plasma lipids and lipoproteins in postmenopausal women using conjugated estrogens: an open randomized comparative study.
Gevers Leuven JA; van der Mooren MJ; Buytenhek R
Fertil Steril; 1995 Sep; 64(3):525-31. PubMed ID: 7641905
[TBL] [Abstract][Full Text] [Related]
3. Effect of conjugated estrogens with and without medrogestone: a prospective study.
van der Mooren MJ; Leuven JA; Rolland R
Maturitas; 1994 May; 19(1):33-42. PubMed ID: 7935030
[TBL] [Abstract][Full Text] [Related]
4. Effects of conjugated equine oestrogens with and without the addition of cyclical medrogestone on hot flushes, liver function, blood pressure and endocrinological indices.
Sonnendecker EW; Polakow ES
S Afr Med J; 1990 Mar; 77(6):281-5. PubMed ID: 2156343
[TBL] [Abstract][Full Text] [Related]
5. Psychological changes effected by estrogen-progestogen and clonidine treatment in climacteric women.
Gerdes LC; Sonnendecker EW; Polakow ES
Am J Obstet Gynecol; 1982 Jan; 142(1):98-104. PubMed ID: 6275706
[TBL] [Abstract][Full Text] [Related]
6. [Effect of combined conjugated estrogen-medrogestone replacement therapy on lipid profiles, climacteric symptoms and the endometrium].
Belaisch J; Nappi C; Affinito P; De Gezelle H; Botelho M; Oliveira HM; Martinez-Oliveira J; Gonzaga F
J Gynecol Obstet Biol Reprod (Paris); 2000 Feb; 29(1):29-40. PubMed ID: 10675831
[TBL] [Abstract][Full Text] [Related]
7. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.
Bayrak A; Aldemir DA; Bayrak T; Corakçi A; Dursun P
Arch Gynecol Obstet; 2006 Aug; 274(5):289-96. PubMed ID: 16810536
[TBL] [Abstract][Full Text] [Related]
8. Effects of medrogestone and conjugated oestrogens on serum lipid and lipoprotein concentrations.
Teichmann AT; Wieland H; Cremer P; Hinney B; Kuhn W; Seidel D
Maturitas; 1985 Nov; 7(4):343-50. PubMed ID: 3001482
[TBL] [Abstract][Full Text] [Related]
9. The effects of conjugated equine oestrogens with and without a cyclical progestogen on lipoproteins, and HDL subfractions in postmenopausal women.
Farish E; Fletcher CD; Hart DM; Teo HT; Alazzawi F; Howie C
Acta Endocrinol (Copenh); 1986 Sep; 113(1):123-7. PubMed ID: 3020851
[TBL] [Abstract][Full Text] [Related]
10. A comparison of oestrogen-progestogen with clonidine in the climacteric syndrome.
Sonnendecker EW; Polakow ES
S Afr Med J; 1980 Nov; 58(19):753-6. PubMed ID: 6252641
[TBL] [Abstract][Full Text] [Related]
11. The independent effects of exercise and estrogen on lipids and lipoproteins in postmenopausal women.
Lindheim SR; Notelovitz M; Feldman EB; Larsen S; Khan FY; Lobo RA
Obstet Gynecol; 1994 Feb; 83(2):167-72. PubMed ID: 8290176
[TBL] [Abstract][Full Text] [Related]
12. Effects of estrogen dose and smoking on lipid and lipoprotein levels in postmenopausal women.
Krauss RM; Perlman JA; Ray R; Petitti D
Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1606-11. PubMed ID: 2837088
[TBL] [Abstract][Full Text] [Related]
13. The effects of estradiol valerate plus medroxyprogesterone acetate and conjugated estrogens plus medrogestone on climacteric symptoms and metabolic variables in perimenopausal women.
Egarter C; Geurts P; Boschitsch E; Speiser P; Huber J
Acta Obstet Gynecol Scand; 1996 Apr; 75(4):386-93. PubMed ID: 8638462
[TBL] [Abstract][Full Text] [Related]
14. Changes in plasma lipoprotein and apolipoprotein composition in relation to oral versus percutaneous administration of estrogen alone or in cyclic association with utrogestan in menopausal women.
Moorjani S; Dupont A; Labrie F; De Lignieres B; Cusan L; Dupont P; Mailloux J; Lupien PJ
J Clin Endocrinol Metab; 1991 Aug; 73(2):373-9. PubMed ID: 1649840
[TBL] [Abstract][Full Text] [Related]
15. Impact of hormone replacement therapy on postprandial lipoproteins and lipoprotein(a) in normolipidemic postmenopausal women.
Julius U; Fritsch H; Fritsch W; Rehak E; Fücker K; Leonhardt W; Hanefeld M
Clin Investig; 1994 Jul; 72(7):502-7. PubMed ID: 7981577
[TBL] [Abstract][Full Text] [Related]
16. The effects of conjugated equine estrogens plus cyclical dydrogesterone on serum lipoproteins and apoproteins in postmenopausal women.
Fletcher CD; Farish E; Dagen MM; Alazzawi F; McQueen D; Hart DM
Acta Endocrinol (Copenh); 1988 Mar; 117(3):339-42. PubMed ID: 2837887
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the effects of raloxifene and conjugated equine estrogen on bone and lipids in healthy postmenopausal women.
Reid IR; Eastell R; Fogelman I; Adachi JD; Rosen A; Netelenbos C; Watts NB; Seeman E; Ciaccia AV; Draper MW
Arch Intern Med; 2004 Apr; 164(8):871-9. PubMed ID: 15111373
[TBL] [Abstract][Full Text] [Related]
18. Sonographic changes in the endometrium of climacteric women during hormonal treatment.
Schurz B; Metka M; Heytmanek G; Wimmer-Greinecker G; Reinold E
Maturitas; 1988 Mar; 9(4):367-74. PubMed ID: 2837621
[TBL] [Abstract][Full Text] [Related]
19. Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms, and lipid-lipoprotein profiles in surgical menopause.
Watts NB; Notelovitz M; Timmons MC; Addison WA; Wiita B; Downey LJ
Obstet Gynecol; 1995 Apr; 85(4):529-37. PubMed ID: 7898828
[TBL] [Abstract][Full Text] [Related]
20. Effects of estrogen/medrogestone therapy on the apoprotein B-containing lipoproteins in postmenopausal women with type 2 diabetes mellitus under satisfactory and non-satisfactory glycemic control.
Aguilar-Salinas CA; Arita Melzer O; Sauque Reyna L; Lopez A; Velasco Perez ML; Guillen LE; Gomez Perez FJ; Rull Rodrigo JA
Isr Med Assoc J; 2001 Feb; 3(2):137-43. PubMed ID: 11344825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
